Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-010874
Filing Date
2025-03-28
Accepted
2025-03-28 09:03:10
Documents
1
Period of Report
2024-11-30
Effectiveness Date
2025-03-28

Document Format Files

Seq Description Document Type Size
1 ARS ny20042834x3_ars.pdf ARS 3876190
  Complete submission text file 0001140361-25-010874.txt   5340337
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: ARS | Act: 34 | File No.: 001-39398 | Film No.: 25781767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)